查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1459779

生物成像试剂市场 - 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Biological Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 232 Pages | 商品交期: 2-10个工作天内

价格

生物成像试剂市场 - 报告范围

TMR 关于全球生物成像试剂市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球生物成像试剂的收入2017-2031年期间的市场，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球生物成像试剂市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解生物成像试剂市场。

市场概况
2022年市场价​​值 168 亿美元
2031 年市场价值 269 亿美元
CAGR 5.4%

该报告深入探讨了全球生物成像试剂市场的竞争格局。全球生物成像试剂市场的主要参与者已被确定，并且每位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球生物成像试剂市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按类别

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依类别，2017-2031
    • 显影剂
    • 光学试剂
    • 核子剂
  • 市场吸引力：按类别

第 7 章：全球市场分析与预测：按模式

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按模式，2017-2031
    • 核磁共振成像
    • 超音波
    • X 光和 CT
    • 核
      • 宠物
      • SPECT
    • 光学成像
    • 其他的
    • 7.4 市场吸引力：依形态分类

第 8 章：全球市场分析与预测：按应用分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 体外
      • 蛋白质体学
      • 基因组学
      • 细胞生物学
    • 体内
  • 市场吸引力：按应用分类

第 9 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 诊断实验室
    • 生命科学公司
    • 影像中心
    • 学术及研究机构
    • 其他的
  • 市场吸引力：按最终用户划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Bayer AG
    • Thermo Fisher Scientific, Inc.
    • PerkinElmer, Inc.
    • Guerbet
    • Lantheus Holdings, Inc.
    • Bracco SpA
    • GE Healthcare
    • Becton, Dickinson and Company (BD)
    • Siemens Healthineers
    • Luminex Corporation
Product Code: TMRGL48474

Biological Imaging Reagents Market - Scope of Report

TMR's report on the global biological imaging reagents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global biological imaging reagents market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biological imaging reagents market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the biological imaging reagents market.

Market Snapshot
Market Value in 2022US$ 16.8 Bn
Market Value in 2031US$ 26.9 Bn
CAGR5.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biological imaging reagents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biological imaging reagents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biological imaging reagents market.

The report delves into the competitive landscape of the global biological imaging reagents market. Key players operating in the global biological imaging reagents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biological imaging reagents market profiled in this report.

Key Questions Answered in Global biological imaging reagents Market Report:

  • What is the sales/revenue generated by biological imaging reagents across all regions during the forecast period?
  • What are the opportunities in the global biological imaging reagents market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biological Imaging Reagents Market - Research Objectives and Research Approach

The comprehensive report on the global biological imaging reagents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global biological imaging reagents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global biological imaging reagents market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biological Imaging Reagents Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Class, 2017-2031
    • 6.3.1. Contrast Agents
    • 6.3.2. Optical Reagents
    • 6.3.3. Nuclear Agents
  • 6.4. Market Attractiveness, by Class

7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Modality, 2017-2031
    • 7.3.1. MRI
    • 7.3.2. Ultrasound
    • 7.3.3. X-Ray & CT
    • 7.3.4. Nuclear
      • 7.3.4.1. PET
      • 7.3.4.2. SPECT
    • 7.3.5. Optical Imaging
    • 7.3.6. Others
    • 7.3.7. 7.4 Market Attractiveness, by Modality

8. Global Biological Imaging Reagents Market Analysis and Forecast, By Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Application, 2017-2031
    • 8.3.1. In Vitro
      • 8.3.1.1. Proteomics
      • 8.3.1.2. Genomics
      • 8.3.1.3. Cell Biology
    • 8.3.2. In Vivo
  • 8.4. Market Attractiveness, By Application

9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Diagnostic Laboratories
    • 9.3.2. Life Science Companies
    • 9.3.3. Imaging Centers
    • 9.3.4. Academic & Research Institutes
    • 9.3.5. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Biological Imaging Reagents Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Biological Imaging Reagents Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Class, 2017-2031
    • 11.2.1. Contrast Agents
    • 11.2.2. Optical Reagents
    • 11.2.3. Nuclear Agents
  • 11.3. Market Attractiveness, by Class
  • 11.4. Market Value Forecast, by Modality, 2017-2031
    • 11.4.1. MRI
    • 11.4.2. Ultrasound
    • 11.4.3. X-Ray & CT
    • 11.4.4. Nuclear
      • 11.4.4.1. PET
      • 11.4.4.2. SPECT
    • 11.4.5. Optical Imaging
    • 11.4.6. Others
  • 11.5. Market Attractiveness, by Modality
  • 11.6. Market Value Forecast, By Application, 2017-2031
    • 11.6.1. In Vitro
      • 11.6.1.1. Proteomics
      • 11.6.1.2. Genomics
      • 11.6.1.3. Cell Biology
    • 11.6.2. In Vivo
  • 11.7. Market Attractiveness, By Application
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Diagnostic Laboratories
    • 11.8.2. Life Science Companies
    • 11.8.3. Imaging Centers
    • 11.8.4. Academic & Research Institutes
    • 11.8.5. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Class
    • 11.11.2. By Modality
    • 11.11.3. By Application
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Biological Imaging Reagents Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Class, 2017-2031
    • 12.2.1. Contrast Agents
    • 12.2.2. Optical Reagents
    • 12.2.3. Nuclear Agents
  • 12.3. Market Attractiveness, by Class
  • 12.4. Market Value Forecast, by Modality, 2017-2031
    • 12.4.1. MRI
    • 12.4.2. Ultrasound
    • 12.4.3. X-Ray & CT
    • 12.4.4. Nuclear
      • 12.4.4.1. PET
      • 12.4.4.2. SPECT
    • 12.4.5. Optical Imaging
    • 12.4.6. Others
  • 12.5. Market Attractiveness, by Modality
  • 12.6. Market Value Forecast, By Application, 2017-2031
    • 12.6.1. In Vitro
      • 12.6.1.1. Proteomics
      • 12.6.1.2. Genomics
      • 12.6.1.3. Cell Biology
    • 12.6.2. In Vivo
  • 12.7. Market Attractiveness, By Application
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Diagnostic Laboratories
    • 12.8.2. Life Science Companies
    • 12.8.3. Imaging Centers
    • 12.8.4. Academic & Research Institutes
    • 12.8.5. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Class
    • 12.11.2. By Modality
    • 12.11.3. By Application
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Class, 2017-2031
    • 13.2.1. Contrast Agents
    • 13.2.2. Optical Reagents
    • 13.2.3. Nuclear Agents
  • 13.3. Market Attractiveness, by Class
  • 13.4. Market Value Forecast, by Modality, 2017-2031
    • 13.4.1. MRI
    • 13.4.2. Ultrasound
    • 13.4.3. X-Ray & CT
    • 13.4.4. Nuclear
      • 13.4.4.1. PET
      • 13.4.4.2. SPECT
    • 13.4.5. Optical Imaging
    • 13.4.6. Others
  • 13.5. Market Attractiveness, by Modality
  • 13.6. Market Value Forecast, By Application, 2017-2031
    • 13.6.1. In Vitro
      • 13.6.1.1. Proteomics
      • 13.6.1.2. Genomics
      • 13.6.1.3. Cell Biology
    • 13.6.2. In Vivo
  • 13.7. Market Attractiveness, By Application
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Diagnostic Laboratories
    • 13.8.2. Life Science Companies
    • 13.8.3. Imaging Centers
    • 13.8.4. Academic & Research Institutes
    • 13.8.5. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Class
    • 13.11.2. By Modality
    • 13.11.3. By Application
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Biological Imaging Reagents Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Class, 2017-2031
    • 14.2.1. Contrast Agents
    • 14.2.2. Optical Reagents
    • 14.2.3. Nuclear Agents
  • 14.3. Market Attractiveness, by Class
  • 14.4. Market Value Forecast, by Modality, 2017-2031
    • 14.4.1. MRI
    • 14.4.2. Ultrasound
    • 14.4.3. X-Ray & CT
    • 14.4.4. Nuclear
      • 14.4.4.1. PET
      • 14.4.4.2. SPECT
    • 14.4.5. Optical Imaging
    • 14.4.6. Others
  • 14.5. Market Attractiveness, by Modality
  • 14.6. Market Value Forecast, By Application, 2017-2031
    • 14.6.1. In Vitro
      • 14.6.1.1. Proteomics
      • 14.6.1.2. Genomics
      • 14.6.1.3. Cell Biology
    • 14.6.2. In Vivo
  • 14.7. Market Attractiveness, By Application
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Diagnostic Laboratories
    • 14.8.2. Life Science Companies
    • 14.8.3. Imaging Centers
    • 14.8.4. Academic & Research Institutes
    • 14.8.5. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Class
    • 14.11.2. By Modality
    • 14.11.3. By Application
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Class, 2017-2031
    • 15.2.1. Contrast Agents
    • 15.2.2. Optical Reagents
    • 15.2.3. Nuclear Agents
  • 15.3. Market Attractiveness, by Class
  • 15.4. Market Value Forecast, by Modality, 2017-2031
    • 15.4.1. MRI
    • 15.4.2. Ultrasound
    • 15.4.3. X-Ray & CT
    • 15.4.4. Nuclear
      • 15.4.4.1. PET
      • 15.4.4.2. SPECT
    • 15.4.5. Optical Imaging
    • 15.4.6. Others
  • 15.5. Market Attractiveness, by Modality
  • 15.6. Market Value Forecast, By Application, 2017-2031
    • 15.6.1. In Vitro
      • 15.6.1.1. Proteomics
      • 15.6.1.2. Genomics
      • 15.6.1.3. Cell Biology
    • 15.6.2. In Vivo
  • 15.7. Market Attractiveness, By Application
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Diagnostic Laboratories
    • 15.8.2. Life Science Companies
    • 15.8.3. Imaging Centers
    • 15.8.4. Academic & Research Institutes
    • 15.8.5. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Class
    • 15.11.2. By Modality
    • 15.11.3. By Application
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Bayer AG
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. PerkinElmer, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Guerbet
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Lantheus Holdings, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Bracco S.p.A.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. GE Healthcare
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Becton, Dickinson and Company (BD)
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Siemens Healthineers
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Luminex Corporation
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017-2031
  • Table 02: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017-2031
  • Table 03: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, By Application, 2017-2031
  • Table 04: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017-2031
  • Table 08: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017-2031
  • Table 09: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, By Application, 2017-2031
  • Table 10: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017-2031
  • Table 13: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017-2031
  • Table 14: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 15: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017-2031
  • Table 16: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017-2031
  • Table 17: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017-2031
  • Table 19: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017-2031
  • Table 20: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017-2031
  • Table 22: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017-2031

List of Figures

  • Figure 01: Global Biological Imaging Reagents Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Biological Imaging Reagents Market Revenue (US$ Mn), by Class, 2022
  • Figure 03: Global Biological Imaging Reagents Market Value Share, by Class, 2022
  • Figure 04: Global Biological Imaging Reagents Market Revenue (US$ Mn), by Modality, 2022
  • Figure 05: Global Biological Imaging Reagents Market Value Share, by Modality, 2022
  • Figure 06: Global Biological Imaging Reagents Market Revenue (US$ Mn), By Application, 2022
  • Figure 07: Global Biological Imaging Reagents Market Value Share, By Application, 2022
  • Figure 08: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 09: Global Biological Imaging Reagents Market Value Share Analysis, by Class, 2022-2031
  • Figure 10: Global Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023-2031
  • Figure 11: Global Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022-2031
  • Figure 12: Global Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023-2031
  • Figure 13: Global Biological Imaging Reagents Market Value Share Analysis, By Application, 2022-2031
  • Figure 14: Global Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023-2031
  • Figure 15: Global Biological Imaging Reagents Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 16: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 17: North America Biological Imaging Reagents Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 18: North America Biological Imaging Reagents Market Value Share Analysis, by Country, 2022-2031
  • Figure 19: North America Biological Imaging Reagents Market Value Share Analysis, by Class, 2022-2031
  • Figure 20: North America Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022-2031
  • Figure 21: North America Biological Imaging Reagents Market Value Share Analysis, By Application, 2022-2031
  • Figure 22: North America Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023-2031
  • Figure 23: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 24: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Europe Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 26: Europe Biological Imaging Reagents Market Value Share Analysis, by Class, 2022-2031
  • Figure 27: Europe Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022-2031
  • Figure 28: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023-2031
  • Figure 29: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023-2031
  • Figure 30: Europe Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023-2031
  • Figure 31: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 32: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 33: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Class, 2022-2031
  • Figure 34: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022-2031
  • Figure 35: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023-2031
  • Figure 36: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023-2031
  • Figure 37: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 38: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 39: Latin America Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 40: Latin America Biological Imaging Reagents Market Value Share Analysis, by Class, 2022-2031
  • Figure 41: Latin America Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022-2031
  • Figure 42: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023-2031
  • Figure 43: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023-2031
  • Figure 44: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 47: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Class, 2022-2031
  • Figure 48: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022-2031
  • Figure 49: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, By Application, 2022-2031
  • Figure 50: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023-2031
  • Figure 52: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023-2031
  • Figure 53: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023-2031
  • Figure 54: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by End-user, 2023-2031